1. DNA Methyltransferase Inhibitors: Development and Applications
   Marie Lopez et al, 2016 CrossRef
2. Potential role for all-trans retinoic acid in nonpromyelocytic acute myeloid leukemia
   Hayley S Ma et al, 2016, International Journal of Hematologic Oncology CrossRef
3. Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia
   Yan Lin et al, 2019, J Int Med Res CrossRef
4. All-trans retinoic acid induces p53-depenent apoptosis in human hepatocytes by activating p14 expression via promoter hypomethylation
   Shin-Hee Heo et al, 2015, Cancer Letters CrossRef
5. DNA Methylation: Biological Implications and Modulation of Its Aberrant Dysregulation
   Alessia Lucidi et al, 2019 CrossRef
6. Changes in expression of WT1 during induced differentiation of the acute myeloid leukemia cell lines by treatment with 5-aza-2′-deoxycytidine and all-trans retinoic acid
   LILI XIANG et al, 2016 CrossRef
7. Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy
   Wei Wu et al, 2016, Ann Hematol CrossRef
8. Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies
   Kelly J. Norsworthy et al, 2016, Leukemia Research CrossRef
9. All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex
   Lu Wang et al, 2022, Br J Cancer CrossRef
10. Exploring the nexus of nuclear receptors in hematological malignancies
    Mukesh Kumar Manickasamy et al, 2024, Cell. Mol. Life Sci. CrossRef